Back
Galectin Therapeutics Stock Price Chart
Free Stock Analysis Report: See The True Value of Any Stock
Analyze Any Stock Free
Sell
8
GALT
Galectin Therapeutics
Last Price:
$1.10
Seasonality Move:
29.37%
7 Day Trial
ALL ACCESS PASS
$
7
Try a Free Stock Analysis With Definitive Buy Sell Hold Ratings
Analyze Any Stock Free-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GALT is experiencing selling pressure, which indicates risk of future bearish movement.
Galectin Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.17 | Sell |
| 20-day SMA: | 1.47 | Sell |
| 50-day SMA: | 2.18 | Sell |
| 200-day SMA: | 2.58 | Sell |
| 8-day EMA: | 1.19 | Sell |
| 20-day EMA: | 1.46 | Sell |
| 50-day EMA: | 1.94 | Sell |
| 200-day EMA: | 2.31 | Sell |
Galectin Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.33 | Sell |
| Relative Strength Index (14 RSI): | 33.99 | Sell |
| Chaikin Money Flow: | -454221 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.08 - 2.16) | Sell |
| Bollinger Bands (100): | (1.85 - 2.93) | Sell |
Galectin Therapeutics Technical Analysis
| Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Galectin Therapeutics Stock
Is Galectin Therapeutics Stock a Buy?
-
Galectin Therapeutics share price is 1.13 while GALT 8-day simple moving average is 1.17, which is a Sell signal.
-
The stock price of GALT is 1.13 while Galectin Therapeutics 20-day SMA is 1.47, which makes it a Sell.
-
Galectin Therapeutics 50-day simple moving average is 2.18 while GALT share price is 1.13, making it a Sell technically.
-
GALT stock price is 1.13 and Galectin Therapeutics 200-day simple moving average is 2.58, creating a Sell signal.
GALT Technical Analysis vs Fundamental Analysis
Sell
8
Galectin Therapeutics (GALT)
is a Sell
Is Galectin Therapeutics a Buy or a Sell?
-
Galectin Therapeutics stock is rated a SellThe current Galectin Therapeutics [GALT] share price is $1.13. The Score for GALT is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
Galectin Therapeutics Stock Info
Market Cap:
70.9M
Price in USD:
1.13
Share Volume:
454.2K
Galectin Therapeutics 52-Week Range
52-Week High:
4.27
52-Week Low:
0.73
Sell
8
Galectin Therapeutics (GALT)
is a Sell
Galectin Therapeutics Share Price Forecast
-
What is the Galectin Therapeutics stock price today?The Galectin Therapeutics stock price is 1.13 USD today.
-
Will GALT stock go up or go down?Galectin Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Galectin Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Galectin Therapeutics is overvalued.
Is Galectin Therapeutics Stock a Buy?
-
Galectin Therapeutics share price is 1.13 while GALT 8-day exponential moving average is 1.19, which is a Sell signal.
-
The stock price of GALT is 1.13 while Galectin Therapeutics 20-day EMA is 1.46, which makes it a Sell.
-
Galectin Therapeutics 50-day exponential moving average is 1.94 while GALT share price is 1.13, making it a Sell technically.
-
GALT stock price is 1.13 and Galectin Therapeutics 200-day simple moving average is 2.31, creating a Sell signal.
Technical Analysis of Galectin Therapeutics
Should I short Galectin Therapeutics stock?
-
GALT Moving Average Covergence Divergence (MACD) indicator is -0.33, suggesting Galectin Therapeutics is a Sell
-
Galectin Therapeutics Relative Strength Index (RSI) is 33.99, which suggest Galectin Therapeutics is oversold
-
The Bollinger Bands (25) for Galectin Therapeutics is (1.08 - 2.16), which suggest Galectin Therapeutics is a Sell
-
The Bollinger Bands (100) for Galectin Therapeutics is (1.85 - 2.93), which suggest Galectin Therapeutics is a Sell
* Galectin Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.